Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edesa Biotech (EDSA) Invested Capital (2016 - 2022)

Edesa Biotech's Invested Capital history spans 10 years, with the latest figure at $11.8 million for Q2 2022.

  • For Q2 2022, Invested Capital fell 25.1% year-over-year to $11.8 million; the TTM value through Jun 2022 reached $11.8 million, down 25.1%, while the annual FY2021 figure was $13.1 million, 96.92% up from the prior year.
  • Invested Capital for Q2 2022 was $11.8 million at Edesa Biotech, down from $17.0 million in the prior quarter.
  • Across five years, Invested Capital topped out at $19.3 million in Q1 2021 and bottomed at $2.8 million in Q1 2019.
  • The 5-year median for Invested Capital is $6.6 million (2020), against an average of $8.4 million.
  • The largest annual shift saw Invested Capital crashed 56.85% in 2018 before it surged 195.83% in 2021.
  • A 5-year view of Invested Capital shows it stood at $3.2 million in 2018, then soared by 31.71% to $4.2 million in 2019, then soared by 86.25% to $7.9 million in 2020, then soared by 33.78% to $10.5 million in 2021, then grew by 12.21% to $11.8 million in 2022.
  • Per Business Quant, the three most recent readings for EDSA's Invested Capital are $11.8 million (Q2 2022), $17.0 million (Q1 2022), and $10.5 million (Q4 2021).